cAMP/EPAC Signaling Enables ETV2 to Induce Endothelial Cells with High Angiogenesis Potential

Jae-Jun Kim,Da-Hyun Kim,Jin Young Lee,Byung-Chul Lee,Insung Kang,Myung Geun Kook,Dasom Kong,Soon Won Choi,Heung-Myong Woo,Dong-Ik Kim,Kyung-Sun Kang
DOI: https://doi.org/10.1016/j.ymthe.2019.11.019
IF: 12.91
2020-02-01
Molecular Therapy
Abstract:<p>Although the generation of ETV2-induced endothelial cells (iECs) from human fibroblasts serves as a novel therapeutic strategy in regenerative medicine, the process is inefficient, resulting in incomplete iEC angiogenesis. Therefore, we employed ChIP-sequencing and identified molecular mechanisms underlying ETV2-mediated endothelial transdifferentiation to efficiently produce iECs retaining appropriate functionality in long-term culture. We revealed that the majority of ETV2 targets in human fibroblasts are related to vasculature development and signaling transduction pathways including Rap1 signaling. From a screening of signaling pathway modulators, we confirmed that forskolin facilitated efficient and rapid iEC reprogramming via activation of cAMP/EPAC/RAP1 axis. The iECs obtained via cAMP signaling activation showed superior angiogenesis <em>in vivo</em> as well as <em>in vitro</em>. Moreover, these cells could form aligned endothelium along the vascular lumen <em>ex vivo</em> when seeded into decellularized liver scaffold. Overall, our study provided evidence that cAMP/EPAC/RAP1 axis is required for the efficient generation of iECs with angiogenesis potential.</p>
genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology
What problem does this paper attempt to address?